Skip to main content

Saphium Biotechnology

MaterialsKapfenstein, AustriaFounded 2015· One of 955 Materials companies tracked by AMPulse

Develops 100% compostable, bio-based PHA (polyhydroxyalkanoate) filaments for FDM 3D printing, produced via microbial fermentation to replace petroleum-based plastics.

CEO / Founder
Christof Winkler-Hermaden
Team Size
1-10
Stage
Active
Total Funding
$253K
Key Investors
SOSV (RebelBio Accelerator)

Technology & Products

Key Products

PHAbulous Philaments (PHA 3D printing filament); Legumino® (Rhizobia inoculant for agriculture); Custom bioplastic compounds

Technological Advantage

CLAIMED: 100% compostable, non-toxic, 60-day soil degradation, fertilizer byproduct. VERIFIED: PHA chemistry is scientifically established; 2015 Kickstarter validated market demand; SOSV/RebelBio accelerator backing. DEFENSIBLE: Proprietary microbial strains and fermentation optimization (trade secret), though PHA polymer class is public domain.

Differentiation

Value Proposition

Eliminates toxic additives and microplastic pollution by providing a fully compostable, non-toxic 3D printing filament that degrades in soil within 60 days while acting as a fertilizer, reducing environmental liability and aligning with circular economy mandates.

How They Differentiate

Unlike standard PLA or ABS filaments that require industrial composting or leave microplastics, Saphium's pure PHA filament degrades in ambient soil within 60 days and enriches soil. Compared to bulk PHA resin producers (e.g., Danimer), Saphium focuses on ready-to-use, extruded 3D printing filament formats optimized for direct AM applications.

Market & Competition

Target Customers

Sustainable product manufacturers, 3D printing service bureaus, prosumer makers, and agricultural sector partners

Industry Verticals

Additive Manufacturing; Sustainable Packaging; Agriculture; Consumer Goods

Competitors

Fillamentum; Polymaker; Danimer Scientific

Growth & Milestones

Growth Metrics

The company has 175 LinkedIn followers and was reported to have $1 million in annual revenue in 2025.

Major Milestones

2015: Accepted into RebelBio Accelerator (SOSV) in Cork, Ireland; 2015: Launched 'PHAbulous Philaments' Kickstarter campaign; 2019: Expanded into microbiological agricultural products (Legumino®); 2020s: Established commercial presence in European sustainable materials market